Hepatobiliary malignancy represents a challenging group of diseases with limited treatment options. Established therapies for hepatobiliary cancer include surgical resection, liver hepatodren efectos secundarios transplantation, chemotherapy, and radiation therapy. However, these approaches often face limitations due to the aggressive nature of the